Kevin Buda

ORCID: 0000-0003-3465-5681
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanical Circulatory Support Devices
  • Cardiac Arrest and Resuscitation
  • Cardiac Imaging and Diagnostics
  • Cardiac Structural Anomalies and Repair
  • Coronary Interventions and Diagnostics
  • Cardiac Valve Diseases and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Infective Endocarditis Diagnosis and Management
  • Acute Myocardial Infarction Research
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Heart Failure Treatment and Management
  • Venous Thromboembolism Diagnosis and Management
  • Peripheral Artery Disease Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Cardiovascular Function and Risk Factors
  • Cardiac tumors and thrombi
  • Kawasaki Disease and Coronary Complications
  • Acute Ischemic Stroke Management
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular Syncope and Autonomic Disorders
  • Coronary Artery Anomalies
  • Pericarditis and Cardiac Tamponade
  • Healthcare Policy and Management

Hennepin Healthcare Research Institute
2020-2025

Abbott Northwestern Hospital
2020-2025

Allina Health
2024

Hennepin County Medical Center
2019-2024

Minneapolis Heart Institute Foundation
2022-2024

University of Vermont
2021

University of Connecticut
2021

Lawrence General Hospital
2020

Carney Hospital
2020

University of Arkansas for Medical Sciences
2020

Abstract Aims Despite increased temporary mechanical circulatory support (tMCS) utilization for acute myocardial infarction complicated by cardiogenic shock (AMI-CS), data regarding efficacy and optimal timing tMCS are limited. This study aimed to describe outcomes based on in AMI-CS identify predictors of 30-day mortality readmission. Methods results Patients with identified the National Readmissions Database were grouped according use early (<24 h) vs. delayed (≥24 tMCS. The...

10.1093/ehjacc/zuae034 article EN European Heart Journal Acute Cardiovascular Care 2024-03-19

Abstract Objectives We examined the 0- and 2-h diagnostic performance of Mindray high-sensitivity cardiac troponin I (hs-cTnI) assay using two predefined sex-specific 99th percentile upper reference limits (URL) in patients with normal electrocardiograms to aid diagnosis myocardial infarction (MI). Methods Consecutive emergency department undergoing serial testing on clinical indication were studied ‘Mindray hs-cTnI Assay Analytical Clinical Evaluation for Diagnosis RIsk Assessment...

10.1515/cclm-2024-1373 article EN Clinical Chemistry and Laboratory Medicine (CCLM) 2025-02-07

Consumer-grade smart devices, including smartwatches and smartphones, are potentially valuable tools in detecting cardiac arrhythmias, particularly atrial fibrillation, their use is increasing. These which photoplethys mography, show remarkably high sensitivity specificity for detection of with implications stroke prevention management at-risk patients. The ability the devices to detect fibrillation being compared single-lead electrocardiography. Physicians will increasingly be asked...

10.3949/ccjm.91a.23030 article EN Cleveland Clinic Journal of Medicine 2024-01-01

Abstract Objectives We determined the efficacy of a high sensitivity cardiac troponin I (hs-cTnI) assay for newly derived 0 h and 0/2-h rule-out concentrations myocardial infarction safety incremental changes at low concentrations. Methods Consecutive, emergency department patients undergoing serial hs-cTnI testing on clinical indication were studied in ‘Mindray Assay Analytical Clinical Evaluation Diagnosis RIsk Assessment Myocardial InfarctIon’ (MERITnI) trial. Primary outcome was...

10.1515/cclm-2024-1387 article EN Clinical Chemistry and Laboratory Medicine (CCLM) 2025-03-24

10.1016/j.jscai.2025.103183 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2025-05-01

Amniotic fluid embolism (AFE) is a potentially lethal complication of pregnancy that results from disruption the maternal–fetal interface and occurs as frequently one in every 8,000 deliveries.1 When AFE complicated by cardiovascular collapse, Society Maternal-Fetal Medicine (SMFM) recommends against routine use veno-arterial extracorporeal membrane oxygenation (V-A ECMO) due to lack robust evidence benefit potential risk for anticoagulation worsen bleeding patients with coagulopathy.2...

10.1097/mat.0000000000002011 article EN ASAIO Journal 2023-07-10

Although current studies support the use of prophylactic distal perfusion catheters (DPCs) to decrease limb ischemia in patients on venoarterial extracorporeal membrane oxygenation (VA ECMO), methods for monitoring differ between studies. We evaluated safety a selective rather than DPC strategy at single center with well-established protocol monitoring. Distal were placed selectively if there was evidence hypoperfusion any point until decannulation. All followed daily by vascular surgery...

10.1097/mat.0000000000002264 article EN ASAIO Journal 2024-06-28

The 2017 American College of Cardiology and Heart Association Task Force on Clinical Practice Guidelines the treatment hypertension recommended lifestyle modification monitoring every 3 to 6 months for patients with stage 1 hypertension. However, guidelines did not include recommendations whose blood pressure is unresponsive therapy. authors review updated AHA position statement, which meant help clinicians manage a low 10-year risk atherosclerotic cardiovascular disease.

10.3949/ccjm.89a.21101 article EN Cleveland Clinic Journal of Medicine 2022-05-01

Abstract Background Mortality for acute myocardial infarction-cardiogenic shock (AMI-CS) remains high. Trends of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) use and outcomes as a function ECMO requirement are not well described. Purpose To identify the trends VA-ECMO AMI-CS in United States. Methods We used Nationwide Readmissions Database (NRD) Healthcare Cost Utilization Project (HCUP) to obtain our cohort. identified patients with requiring using International...

10.1093/eurheartj/ehac544.1325 article EN European Heart Journal 2022-10-01

Background Data comparing MANTA to other vascular closure devices (VCDs) after TAVR is limited.Methods We performed a meta-analysis of all published studies reporting the outcomes vs. VCDs in patients. Outcomes included major and minor complications, bleeding, VCD failure, blood transfusion, additional surgical or endovascular treatment, flow-limiting dissection, hematomas, pseudoaneurysm, change hemoglobin, length stay (LOS). Definitions used were according “Valve Academic Research...

10.1080/24748706.2020.1809755 article EN cc-by-nc-nd Structural Heart 2020-08-13

A 40-year-old male presented with an inferior ST-segment elevation myocardial infarction. Multimodality imaging identified a ventricular septal defect and right free wall dissection. He was bridged percutaneous microaxial left assist device to successful surgical repair. imaging, shock team involvement, mechanical support were critical in ensuring his survival hospital discharge.

10.1016/j.jaccas.2024.102403 article EN cc-by-nc-nd JACC Case Reports 2024-06-13

10.1016/s0735-1097(24)02200-9 article EN Journal of the American College of Cardiology 2024-04-01
Coming Soon ...